Company / EPS (Basic)
NRX Pharmaceuticals, Inc. EPS (Basic) History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.36
FY2025
5-year range
-$3.98 / -$2.36
FY2024-FY2025
Trend
+40.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-2.36 in FY2025.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 40.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -5.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.36 | +40.7% |
| FY2024 | -$3.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026